Canada offers solution to transportation rule threat
This article was originally published in Clinica
A Canadian proposal put forward at a World Health Organization meeting last month could spare many manufacturers in the medical devices and diagnostics industry from the potentially costly repercussions of the forthcoming application of the United Nations international transport regulations concerning dangerous goods to diagnostic specimens. The proposal to split up diagnostic specimens into more and less hazardous categories will be submitted to the committee of experts on the transport of dangerous goods in December 2001.
You may also be interested in...
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.
Amid several new and updated draft guidance documents and the potential approach of the first approval, interchangeability continues to be a buzzword in US biosimilars. AbbVie has projected that two Humira (adalimumab) biosimilars will hold the designation when they launch in 2023.